Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thymoma × Bupivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 32 Breast Neoplasms 24 Lung Neoplasms 12 Pain 11 Agnosia 11 Leiomyoma 7 Pancreatic Neoplasms 5 Neoplasms 5 Prostatic Neoplasms 4 Colorectal Neoplasms 4 Rectal Neoplasms 3 Neuralgia 3 Hot Flashes 3 Colonic Neoplasms 3 Thyroid Nodule 2 Thyroid Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroma 2 Lymphedema 2 Liver Neoplasms 2 Kidney Neoplasms 2 Ileus 2 Hyperparathyroidism 2 Goiter 2 Digestive System Diseases 2 Chronic Pain 2 Breast Cancer Female 2 Brain Neoplasms 2 Adenomyosis 2 Abdominal Cancer 2

Interventions

pembrolizumab 6 Radiotherapy 6 Cyclophosphamide 6 Cisplatin 6 Sunitinib 5 Carboplatin 5 Paclitaxel 4 Thymectomy 3 130-nm albumin-bound paclitaxel 3 selinexor 2 lenvatinib 2 Taxes 2 Robotic Surgical Procedures 2 Ramucirumab 2 Prednisone 2 Pemetrexed 2 Octreotide 2 Nivolumab 2 N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2 Methylprednisolone 2 Imatinib Mesylate 2 Etoposide 2 Erlotinib Hydrochloride 2 Drug Therapy 2 Doxorubicin 2 Chemoradiotherapy 2 Celecoxib 2 zimberelimab 1 vorolanib 1 saracatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06545409 2025-03-25

SPRATS

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Recruiting

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡